iShares Biotechnology ETF

AstraZeneca CEO Pascal Soriot told CNBC on Monday that Summit Therapeutics' lead drug could help power…
Read More...

Novartis has signed a deal worth up to $7.8 billion, in the latest of a flurry of tie-ups between Big Pharma and…
Read More...

The next generation of blockbuster obesity drugs isn't trying to replace GLP-1 medicines.Instead, drugmakers are…
Read More...

Eli Lilly on Wednesday said its experimental combination regimen resulted in greater weight loss than a high dose of…
Read More...

The Eli Lilly and Novo Nordisk logos.Mike Blake | Tom Little | ReutersEvery time Novo urges investors to look ahead,…
Read More...

Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…
Read More...

A young female worker in protective gear carefully carries a container filled with blister-packaged capsules, a…
Read More...

AstraZeneca on Tuesday released full results from two successful late-stage trials on its experimental drug for…
Read More...

FILE PHOTO: The logo of Swiss drugmaker Novartis is seen at the company's new cell and gene therapy factory in Stein,…
Read More...

Blood sample for a lipoprotein(a) test.Md Babul Hosen | Istock | Getty ImagesNovartis' failure in a closely watched…
Read More...